Lead researcher Rebecca Ready, associate professor of psychology at UMass Amherst, says, “Alzheimer’s disease is a progressive neurodegenerative disease in which neuropathology begins to accumulate decades before clinical symptoms are noticeable. In order to maximize the opportunity for preventive interventions and treatment, it’s crucial that we identify early markers. Recent research is consistent with our results showing that a broader focus on early, preclinical markers for this disease is needed.”
“Our data suggest that investigators consider the possibility of subtle changes in processing speed even before clinical symptoms of mild cognitive impairment or Alzheimer’s disease become apparent. The most valuable data about early Alzheimer’s disease will come from long-term studies among high-risk populations, and we hope to expand our current sample and follow them over time to determine which neuropsychological and brain volume measures are related to future cognitive decline.”
Ready and colleagues’ report appears in the current issue of the American Journal of Alzheimer’s Disease and Other Dementias.
In this investigation supported by the UMass Amherst Research Development Office, she and colleagues used parental diagnosis of Alzheimer’s to recruit a genetically-enriched sample of 23 healthy, non-smoking adults (14 women, 9 men) with an average age of 55.8 years. As children of a parent with likely Alzheimer’s, they were considered to be at higher-than-average genetic risk. They agreed to genotyping and participated in several learning and memory, cognitive, motor and visual tests, a mood survey, a saliva assay for the stress hormone cortisol and an MRI.
The selection strategy yielded eight participants, or 35 percent of the original 23, who had the e4 variant of the genetic marker apolipoprotein (ApoE). ApoE e4 is associated with a three- to four-fold greater risk for Alzheimer’s than the estimated 14 to 25 per 100 rate in the wider population. The other 15 subjects had non-E4 variants or alleles of the Apo E gene.
Overall, ApoE e4 participants had similar education levels, verbal IQ scores, marital status, alcohol use, exercise habits, mood, stress levels, and good and bad life experiences over the previous year as participants who were not ApoE e4 positive, the authors say.
Participants attended two laboratory sessions. At the first, they took cognitive tests and were instructed how to collect and store cortisol samples by saliva swab at home over the next two days. Cognitive tests included measures of working memory, long-term memory storage, processing speed and visual scanning, among others. They also completed mood assessment, life events and personality tests. The second session, a few weeks after the first, was for MRI volumetric brain imaging.
Ready and colleagues compared measures for the eight participants in the ApoE e4 subgroup with results of the 15 participants who did not carry the e4 gene. They found that participants with the ApoE e4 marker performed significantly more slowly on an executive function test and had slower processing speed.
ApoE e4 subjects also had less brain volume in white matter. This lower white matter volume was significantly correlated with slower processing speed. “Processing speed and changes in white matter volume are candidate indicators of preclinical decline in Alzheimer’s disease,” Ready explains.
Finally, the ApoE e4 group had significantly greater morning rise in the stress marker cortisol as measured at waking and 30 minutes later, than the non-e4 group, but cortisol level was not associated with cognitive or brain volume measures. More research into associations between ApoE and cortisol is needed, the investigators note.
This study marks a break with past research by studying healthy people in midlife assumed to be at greater risk of developing Alzheimer’s disease than people who do not have a parent with the disease. “The vast majority of research on the effects of ApoE e4 on cognition and brain volume has been conducted on healthy, nondemented groups of older adults,” Ready notes. “We extended this line of research to a genetically-enriched, healthy sample of mid-life adults.”
Rebecca E. Ready | Newswise Science News
Resolving the mystery of preeclampsia
21.10.2016 | Universitätsklinikum Magdeburg
New potential cancer treatment using microwaves to target deep tumors
12.10.2016 | University of Texas at Arlington
Researchers from the Institute for Quantum Computing (IQC) at the University of Waterloo led the development of a new extensible wiring technique capable of controlling superconducting quantum bits, representing a significant step towards to the realization of a scalable quantum computer.
"The quantum socket is a wiring method that uses three-dimensional wires based on spring-loaded pins to address individual qubits," said Jeremy Béjanin, a PhD...
In a paper in Scientific Reports, a research team at Worcester Polytechnic Institute describes a novel light-activated phenomenon that could become the basis for applications as diverse as microscopic robotic grippers and more efficient solar cells.
A research team at Worcester Polytechnic Institute (WPI) has developed a revolutionary, light-activated semiconductor nanocomposite material that can be used...
By forcefully embedding two silicon atoms in a diamond matrix, Sandia researchers have demonstrated for the first time on a single chip all the components needed to create a quantum bridge to link quantum computers together.
"People have already built small quantum computers," says Sandia researcher Ryan Camacho. "Maybe the first useful one won't be a single giant quantum computer...
COMPAMED has become the leading international marketplace for suppliers of medical manufacturing. The trade fair, which takes place every November and is co-located to MEDICA in Dusseldorf, has been steadily growing over the past years and shows that medical technology remains a rapidly growing market.
In 2016, the joint pavilion by the IVAM Microtechnology Network, the Product Market “High-tech for Medical Devices”, will be located in Hall 8a again and will...
'Ferroelectric' materials can switch between different states of electrical polarization in response to an external electric field. This flexibility means they show promise for many applications, for example in electronic devices and computer memory. Current ferroelectric materials are highly valued for their thermal and chemical stability and rapid electro-mechanical responses, but creating a material that is scalable down to the tiny sizes needed for technologies like silicon-based semiconductors (Si-based CMOS) has proven challenging.
Now, Hiroshi Funakubo and co-workers at the Tokyo Institute of Technology, in collaboration with researchers across Japan, have conducted experiments to...
14.10.2016 | Event News
14.10.2016 | Event News
12.10.2016 | Event News
21.10.2016 | Health and Medicine
21.10.2016 | Information Technology
21.10.2016 | Materials Sciences